Simulations Plus completes acquisition of Pro-ficiency Holdings, Inc. to enhance drug development solutions
Simulations Plus completes acquisition of Pro-ficiency Holdings, Inc. to enhance drug development solutions
06/12/24, 12:13 PM
Location
lancasterraleighIndustry
artificial intelligence
consulting
biotechnology
software
analytics
Simulations Plus, Inc. has announced the acquisition of Pro-ficiency Holdings, Inc. This strategic acquisition expands Simulations Plus’ end-to-end offering across the drug development continuum, from establishing pre-clinical protocols to product commercialization. The acquisition brings together two businesses with complementary expertise and services, each grounded in science and focused on applying advanced technologies like AI to enhance actionable data analytics.
Company Info
Location
Lancaster, California, United States
Company info
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide.